Rosacea Blepharoconjunctivitis Treated with a Novel Preparation of Dilute Povidone Iodine and Dimethylsulfoxide: a Case Report and Review of the Literature

被引：9

作者：

Pelletier J.S. ^{[1
,2
]}

Stewart K.P. ^{[1
,3
]}

Capriotti K. ^{[1
,4
]}

Capriotti J.A. ^{[1
,3
]}

机构：

[1] ALC Therapeutics, LLC, Springhouse, PA

[2] Ocean Ophthalmology Group, Miami, FL

[3] Plessen Ophthalmology Consultants, Christiansted, VI

[4] Bryn Mawr Skin and Cancer Institute, Rosemont, PA

来源：

Ophthalmology and Therapy | 2015年 / 4卷 / 2期

关键词：

Blepharitis; Conjunctivitis; Dimethylsulfoxide; Povidone iodine; Rosacea;

D O I：

10.1007/s40123-015-0040-4

中图分类号：

学科分类号：

摘要：

Introduction: Povidone iodine (PVP-I) 10% aqueous solution is a commonly utilized anti-septic employed for sterilization of the ocular surface prior to interventional procedures. Dimethylsulfoxide (DMSO) is a well-known skin penetration agent scarcely utilized in ophthalmic drug formulations. We describe here a low-dose formulation of 1% PVP-I (w/w) in a gel containing DMSO for use in the setting of recalcitrant rosacea blepharoconjunctivitis. A review of the ocular uses of dimethylsulfoxide is also presented. Case report: A 78-year-old male presented with chronic, long-standing blepharitis involving both the anterior and posterior lid margins. Posterior lid and skin inflammatory changes were consistent with ocular rosacea. Previous oral and topical therapies had been largely ineffective at controlling his condition. Conclusion: The topical PVP-I/DMSO system was effective in abating the signs and symptoms of rosacea blepharoconjunctivitis. Further investigation of this novel agent is warranted. © 2015, The Author(s).

引用

页码：143 / 150

页数：7

共 40 条

[31]

Pina Y., Decatur C., Murray T., Et al., Advanced retinoblastoma treatment: targeting hypoxia by inhibition of the mammalian target of rapamycin (mTOR) in LH(BETA)T(AG) retinal tumors, Clin Ophthalmol., 5, pp. 337-343, (2011)

[32]

Luke J., Nassar K., Luke M., Et al., The effect of adjuvant dimethylenastron, a mitotic Kinesin Eg5 inhibitor, in experimental glaucoma filtration surgery, Curr Eye Res, 35, 12, pp. 1090-1098, (2010)

[33]

Hucker H.B., Ahmad P.M., Miller E.A., Absorption, distribution and metabolism of dimethylsulfoxide in the rat, rabbit and guinea pig, J Pharmacol Exp Ther, 154, 1, pp. 176-184, (1966)

[34]

Edelhauser H.F., Gallum A.B., Van Horn D.L., Et al., Uptake and removal of dimethylsulfoxide in rabbit and human corneas during cryopreservation, Cryobiology, 8, pp. 104-107, (1971)

[35]

Bourne W.M., Shearer D.R., Nelson L.R., Human corneal endothelial tolerance to glycerol, dimethylsulfoxide, 1,2-propanediol, and 2,3-butanediol, Cryobiology, 31, 1, pp. 1-9, (1994)

[36]

Pult H., Korb D.R., Blackie C.A., Knop E., Marx E., About vital staining of the eye and eyelids. I. The anatomy, physiology, and pathology of the eyelid margins and the lacrimal puncta by E. Marx. 1924, Optom Vis Sci, 87, 10, pp. 718-724, (2010)

[37]

Tarrand J.J., Lasala P.R., Han X.Y., Rolston K.V., Kontoyiannis D.P., Dimethyl sulfoxide enhances effectiveness of skin antiseptics and reduces contamination rates of blood cultures, J Clin Microbiol, 50, 5, pp. 1552-1557, (2012)

[38]

Patil M., Pharmacology and clinical use of dimethyl sulfoxide (DMSO): a review., Int J Mol Vet Res., 3, 6, (2013)

[39]

Silverman C., Yoshizumi M., Ocular toxicity of experimental intravitreal DMSO, J Toxicol Cutan Ocul Toxicol., 2, 2-3, pp. 193-200, (1983)

[40]

Kiland J., Peterson J., Gabelt B., Kaufman P., Effect of DMSO and exchange volume on outflow resistance washout and response to pilocarpine during anterior chamber perfusion in monkeys, Curr Eye Res, 16, 12, pp. 1215-1220, (1997)

← 1 2 3 4 →